Quarterlytics / Basic Materials / Chemicals - Specialty / IKONICS Corporation

IKONICS Corporation

iknx · NASDAQ Basic Materials
Claim this profile
Ticker iknx
Exchange NASDAQ
Sector Basic Materials
Industry Chemicals - Specialty
Employees 51-200
← All annual reports
FY2003 Annual Report · IKONICS Corporation
Sign in to download
Loading PDF…
IKONICS Now.

Aggressive  momentum  into  new  markets.  The
development of new products to serve those markets.
Continuous strengthening of industry leading brands.
These  are  the  principles  that  place 
solidly in the position of actively creating its future.
Domestically and abroad, in traditional markets and
new venues, using long-proven technologies and state-
of-the art innovation, the IKONICS future is now:

Derived  from  the  Greek  eikon, or  “image,”  the
fundamental business of the IKONICS Corporation is
providing  the  ability  to  create  and  transfer  visual
images. Through processes based in photochemistry,
screen printing, abrasive etching, inkjet printing, laser
imaging and other technologies, IKONICS participates
in a diverse spectrum of markets. Three distinct business
units provide access to these markets accommodating
the need for varying models of distribution:

®

Screen Print
Products is IKONICS’ largest
and  oldest  business  unit  and
most established brand. Begin-
ning as a label printer in 1952
as Chroma-Glo, the company
introduced the Direct/Indirect
printing  method  in  1964.  At
that time, the company altered
its business model from print-
ing to manufacturing. In 1982
the  company  became  The
Chromaline  Corporation  and
began developing and manu-
facturing products to serve the screen printing industry.
Today, the Chromaline brand is a strong asset, providing
IKONICS  the  leverage  to  introduce  new  products
into the screen printing market. 

Screen printing is the oldest
of all printing processes and
exists  today  because  of  its
ability to print on the widest
range  of  surfaces  with  the
broadest  selection  of  inks,
delivering  the  greatest  ink-
film  thickness  of  any  other
printing process

The evolution of the

™ line of inkjet recep-
tive media is an excellent example of the company’s
ability  to  take  advantage  of  this  brand  authority,
moving the company further in the direction of digital
printing—among  the  fastest-growing  segments  of
the screen printing industry. In 2003, the establishment
of AccuBlack as the standard product brand for inkjet
media  set  the  stage  for  the  next  line  extension:
™, which will appeal to the largest-possible

population of printers. 

dominates the awards and recog-
nition,  advertising  specialties  and  gift  markets  in
abrasive etching  technology.  The  acquisition  of
technology in 2003 pro-
DuPont’s 
vides PhotoBrasive the opportunity to further widen
the competitive technology gap within its core markets
and penetrate new markets, well beyond
the division’s traditional base.

Particularly attractive to developing
markets,  in  2003  IKONICS  concen-
trated on exporting the PhotoBrasive
Systems product line to foreign mar-
kets. Countries throughout
Asia, Eastern and Central
Europe,  South  America
and Australia were aggres-
sively  pursued  in  2003.
Evidence  of  this  interna-
tional concentration is the
establishment  of  training
schools  across the globe,
including  a  new  training
center in Singapore in 2003. 

New  RapidMask  HD  allows  for
the  creation  of  etched, photo-
quality halftones.

,

established  as  a  new  business
development focal point for new
technologies,  took  a  major  step
forward  in  2003,  graduating  the
IKONMetals  concept  from  an
idea  to  a  business  development
project with considerable priority
and prominence. 

still  in  development  as  a
product  line,  shows  very
real  potential  in  markets
adjacent to IKONICS’ tra-
ditional  targets  and  others
quite remote. The excitement
surrounding  IKONMetals,
internally and in the beta markets surveyed, continues
to  fuel  the  development  of  this  product  line  and
confirms the value of SplitRock Technologies as an
incubator for creative commercial ideas. 

IKONMETALS  is  a  promising  tech-
nology with applications in several
imaging markets.

Imaging Technologies for Global Markets

Table of Contents

2  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Letter to the Shareholders
3  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Financial Results
8  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Balance Sheets
9  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Statements of Operations
10  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Statements of Stockholders’ Equity
11  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Statements of Cash Flows
12  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Notes to Financial Statements
19  . . . . . . . . . . . . . . . . . . . . . . . . . . .
5-Year History
20  . . . . . . . . . . . . . . . . . . . . . . . . . . .
Board of Directors/Officers

2003 ANNUAL REPORT

1

Letter to the Shareholders

Imaging Technologies for Global Markets

Bill Ulland
Chairman,President and CEO

The  year  2003  marked  further  sales
growth and a strong increase in earnings
for IKONICS. It also was a year where our
base for future growth was strengthened. 
Sales for the year grew 3% to a record
level  of  $12,105,000,  while  earnings
increased by 40% to 40 cents per share.
Sales grew in spite of the abandonment
of an unprofitable line of business, and
the earnings increase comes after a write-
down of $75,000 on an investment. The
company generated $1,401,000 in cash
from operations in 2003, as compared to $249,000 in
2002  and  ended  the  year  with  $1,508,000  in  cash
and cash equivalents. Although the timing of payments
and investments in plant and equipment affects cash
flow, these numbers and our balance sheet indicate
very strong financial health.

Looking ahead, IKONICS’ primary goal in 2004 is
to increase profitable sales and to broaden our customer
base. In 2003, many of the initiatives begun in 2002 have
become reality, creating the foundation for growth. 

In February 2003, we acquired an exclusive license
from DuPont for its RapidMask technology. Rapid-
Mask is the only photoresist film in the abrasive etch-
ing market that is dry-processable, saving time and
improving production efficiency. Our chemists have
reformulated the product to make it more user-friendly.
We have also substantially enhanced the film’s reso-
lution capabilities to the point where detailed, halftone
images now can be etched on glass and other substrates.
New RapidMask HD and RapidMask II were intro-
duced in the third quarter. Not only has the reception
from our traditional customers been very encourag-
ing,  but  we  are  finding  strong  applications  in  new
markets. RapidMask will be the major focus of our
PhotoBrasive Systems Division in 2004. 

We made significant progress in the Asian market
in 2003. This is a rapidly growing market for Chro-
maline products and is virtually untapped for Photo-
Brasive photoresist films. In June we opened a training
center in Singapore and have hosted schools for cus-
tomers throughout the region. We are working closely
with our Indian distributor to introduce RapidMask to
that market and are increasing our efforts in China,
where much of the world’s electronics-related screen
printing is now done. We anticipate significant growth
from Asia in 2004, although there is a certain amount
of unpredictability and risk in this market. 

In  December  2003,  we  applied  for
a patent on IKONMetals Imaging Tech-
nology  and  introduced  prototypes  to
select  customers.  This  technology  has
potentially  broad  application,  possibly
replacing  acid  etching,  machining  and
casting of metals in many instances. The
IKONMetals  technology  is  a  unique
composite metal that can be imaged by
abrasive etching. Initially, we are looking
at  the  plaque  and  signage  industries;
but  customer  feedback  indicates  other
potential  industrial  applications.  Though  product
optimization is ongoing, I anticipate commercialization
of IKONMetals in 2004. 

IKONMetals has the potential to be the third leg of
our stool, joining Chromaline Screen Products and
PhotoBrasive  Systems  as  our  engines  of  growth.
Whether or not this particular technology meets our
expectations,  we  will  continue  to  extend  our  base
into new markets. 

While we have exciting plans for the future, our
core businesses also did well 2003, and we will con-
tinue to support and invest in them. Being involved
in  the  global  market  not  only  buffers  the  effect  of
weakness in one market but helps us develop robust
products that meet a broad set of needs.

I  am  optimistic  about  2004;  but  there  are  some
unknowns. The pending change in the tax treatment
of income generated from exports may increase our
tax rate. In 2003 we benefited from the weak U. S.
dollar-to-Euro exchange rate, and this may change. As
a small, international company, we are affected by
world economies and relatively small write-downs and
financial adjustments can impact our bottom line. 

Our  efforts  in  2000  and  2001  were  focused  on
cleaning up the fallout from the Aicello lawsuit and
coping with a soft economy. In 2002 and 2003 we
returned to profitability, while laying the foundations
for growth. I expect the recent improvements in our
traditional markets to continue and our new initiatives
to  contribute  substantially  to  the  growth  and  prof-
itability of IKONICS in the years ahead.

For the Board of Directors,

William C. Ulland
Chairman, President and CEO

2

IKONICS CORPORATION

Imaging Technologies for Global Markets

MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

The following management discussion and analysis
focuses on those factors that had a material effect on
the  Company’s  financial  results  of  operations  and
financial condition during 2003 and 2002 and should
be read in connection with the Company’s audited
financial statements and notes thereto for the years
ended December 31, 2003 and 2002.

Factors That May Affect Future Results

Certain statements made in this Annual Report on
Form 10-KSB, including those summarized below, are
forward-looking  statements  within  the  meaning  of
the safe harbor provisions of Section 21E of the Secu-
rities Exchange Act of 1934, as amended, that involve
risks and uncertainties, and actual results may differ.
Factors that could cause actual results to differ include
those identified below.

• The Company’s belief that the quality of its receiv-
ables is high and that strong internal controls are
in  place  to  maintain  proper  collections –  This
belief may be impacted by domestic economic
conditions, by economic, political, regulatory or
social conditions in foreign markets, or by the fail-
ure  of  the  Company  to  properly  implement  or
maintain internal controls.

• The belief that the Company’s current financial
resources, cash generated from operations and the
Company’s capacity for debt and/or equity financ-
ing  will  be  sufficient  to  fund  current  and
anticipated  business  operations  and  capital
expenditures. The belief that the Company’s low
debt levels and available line of credit make it
unlikely that a decrease in product demand would
impair the Company’s ability to fund operations –
Changes in anticipated operating results, credit
availability, equity market conditions or the Com-
pany’s debt levels may further enhance or inhibit
the Company’s ability to maintain or raise appro-
priate levels of cash.

• The Company’s expectation that capital expen-
ditures will be funded with cash generated from
operating activities – This expectation may be
affected by changes in the Company’s anticipated

Financial Results

capital expenditure requirements resulting from
unforeseen required maintenance or repairs. The
funding of planned or unforeseen expenditures
may also be affected by changes in anticipated
operating results resulting from decreased sales
or increased operating expenses. 

• The Company’s belief that its vulnerability to
foreign currency fluctuations and general eco-
nomic conditions  in  foreign  countries  is  not
significant –  This  belief  may  be  impacted  by
economic,  political  and  social  conditions  in
foreign markets and changes in regulatory and
competitive conditions or a change in the amount
or geographic focus of the Company’s interna-
tional sales. 

• The  Company’s  plans  to  continue  to  invest
in  research  and  development  efforts,  expedite
internal product development and invest in tech-
nological  alliances,  as  well  as  the  expected
focus and results of such investments – These
plans  and  expectations  may  be  impacted  by
general  market  conditions,  unanticipated
changes in expenses or sales, delays in the devel-
opment of new products, technological advances,
the ability to find suitable and willing technology
partners  or  other  changes  in  competitive  or
market conditions.

• The Company’s efforts to grow its international
business –  These  efforts  may  be  impacted  by
economic, political and social conditions in cur-
rent and anticipated foreign markets, regulatory
conditions in such markets, unanticipated changes
in expenses or sales, changes in competitive con-
ditions or other barriers to entry or expansion.
• The Company’s belief as to future activities that
may  be  undertaken  to  expand  the  Company’s
business – Actual activities undertaken may be
impacted by general market conditions, compet-
itive conditions in the Company’s industry, unan-
ticipated  changes  in  the  Company’s  financial
position  or  the  inability  to  identify  attractive
acquisition targets or other business opportunities.

Critical Accounting Policies

The Company prepares the financial statements in
conformity  with  accounting  principles  generally
accepted in the United States of America. Therefore,

2003 ANNUAL REPORT

3

Financial Results

the Company is required to make certain estimates,
judgments  and  assumptions  that  the  Company
believes are reasonable based upon the information
available.  These  estimates  and  assumptions  affect
the reported amounts of assets and liabilities at the
date  of  the  financial  statements  and  the  reported
amounts of revenues and expenses during the periods
presented. The accounting policies, which IKONICS
believes are the most critical to aid in fully under-
standing and evaluating its reported financial results,
include the following:

Accounts  Receivable. The  Company  performs
ongoing credit evaluations of its customers and adjusts
credit  limits  based  upon  payment  history  and  the
customer’s current credit worthiness, as determined by
review of the current credit information. The Company
continuously monitors collections and payments from
its customers and maintains a provision for estimated
credit  losses  based  upon  historical  experience  and
any specific customer collection issues that have been
identified. While such credit losses have historically
been within expectations and the provisions estab-
lished,  the  Company  cannot  guarantee  that  it  will
continue to experience the same collection history that
has occurred in the past. The general payment terms
are net 30-45 days for domestic customers and net 60-
90 days for foreign customers. 

Inventory. Inventories are valued at the lower rate
of  cost  or  market  value  using  the  last  in,  first  out
(LIFO) method. The Company monitors its inventory
for  obsolescence  and  records  reductions  in  cost
when required. 

Deferred Tax Assets. At December 31, 2003, the
Company had approximately $194,000 of deferred tax
assets. The deferred tax assets result primarily due to
timing differences in intangible assets and property
and equipment. The Company has recorded a $46,000
valuation  allowance  to  reserve  for  items  that  will
more likely than not be realized. The Company has
determined  that  it  is  more  likely  than  not  that  the
remaining  deferred  tax  assets  will  be  realized  and
that an additional valuation allowance for such assets
is not currently required.

Revenue  Recognition. The  Company  recognizes
revenue on products when title passes, which is usu-
ally  upon  shipment.  Freight  billed  to  customers  is
included in sales. Shipping costs are included in cost
of goods sold.

Imaging Technologies for Global Markets

Results of Operations
Year Ended December 31, 2003 Compared to
Year Ended December 31, 2002 

Sales. The Company’s net sales increased 2.6% to
$12.1 million in 2003, compared to net sales of $11.8
million in 2002. Sales in the United States increased
1.8% to $8.2 million in 2003, from $8.0 million in
2002. Sales in the United States slightly increased as
a result of an improvement in the general economic
climate. International sales increased 4.3% to $3.9 mil-
lion from $3.8 million in 2002.

Cost of Goods Sold. Cost of goods sold was $6.6
million, or 54.5% of sales, in 2003 and $6.8 million,
or 57.7% of sales, in 2002. The decrease in cost of
goods sold reflects an improved product mix across all
geographic areas and lower costs for some raw mate-
rials. The Company also ended sales to certain mar-
ginally profitable customers at the beginning of 2003.
Selling,  General  and  Administrative  Expenses.
Selling, general and administrative expenses increased
to $4.2 million, or 34.5% of sales, in 2003 from $3.8
million, or 32.5% of sales, in 2002. The increase reflects
a contingent liability for unpaid state sales tax, higher
sales and marketing expenses, including costs to set up
a training facility in Singapore, and bad debt expense.
Research and Development Expenses. Research and
development expenses were $632,000, or 5.2% of sales,
in 2003 compared to $706,000, or 6.0% of sales, in
2002. The reduction was due to lower patent legal fees,
lower travel expenses and lower production trial costs.
Loss  on  Investment. The  Company  wrote  down
the value of its investment in Apprise Technologies
(“Apprise”) by $75,000 during the second quarter of
2003.  This  write  down  occurred  because  the  latest
issuance price per share of Apprise was below the
value carried on the Company’s books.

Interest  Income. Interest  income  increased  to
$16,000 in 2003, compared to $13,000 for 2002. The
higher interest income is due to the growing amount
of invested funds. Interest is earned primarily from
government  obligation  revenue  bonds  of  various
municipalities and school districts.

Income Taxes. Income taxes were $129,000, or an
effective  rate  of  20.3%,  for  2003  compared  to
$101,000, or an effective rate of 21.9%, for 2002. The
lower  effective  tax  rate  during  2003  relates  to  an
increase in tax benefits of the extraterritorial income
exclusion on foreign sales. 

4

IKONICS CORPORATION

Imaging Technologies for Global Markets

Liquidity and Capital Resources

The Company has financed its operations princi-
pally with funds generated from operations. These
funds have been sufficient to cover the Company’s
normal operating expenditures, annual capital require-
ments, and research and development expenditures.
Cash and cash equivalents were $1,508,000 and
$384,000 at December 31, 2003 and December 31,
2002,  respectively.  The  Company  generated
$1,401,000 in cash from operating activities during
2003 compared to the generation of $249,000 in cash
from operating activities during the same period in
2002.  Cash  provided  by  operating  activities  is  pri-
marily the result of net income adjusted for non-cash
depreciation,  amortization,  loss  on  investment,
provision for doubtful accounts, and certain changes
in working capital components.

During 2003, trade receivables increased by $7,000,
net  of  the  allowance  for  doubtful  accounts.  The
increase  in  receivables  was  driven  by  moderately
higher sales. The Company believes that the quality
of  its  receivables  is  high  and  that  strong  internal
controls are in place to maintain proper collections.
Inventory  levels  increased  by  $35,000,  reflecting
higher  raw  material  levels.  Accounts  payable
decreased by $52,000, reflecting timing of payments
to suppliers. Accrued expenses increased by $207,000
due  to  probable  future  sales  tax  payments  and  the
timing of payroll.

The Company used $277,000 and $336,000 in
cash for investing activities during 2003 and 2002,
respectively.  During  2003,  the  Company  spent
$245,000  on  the  following:  plant  equipment
upgrades to improve efficiency and reduce operat-
ing  costs,  additions  to  the  Company’s  business
software,  improvements  to  the  Company’s  trade
show booths and construction costs on the leased
training facility in Singapore. The Company also
incurred $60,000 in patent application costs that it
records as an asset and amortizes upon successful
completion of the application process. During 2002,
the Company purchased $250,000 in capital equip-
ment  and  business  software  and  spent  $123,000
on  patent  application  costs  and  on  a  license  for
technology applicable to its abrasive etching busi-
ness. During 2003 the Company purchased $84,000
in marketable securities and sold $106,000 in mar-
ketable securities. 

Financial Results

During  2002,  the  Company  repurchased  23,500
shares of its outstanding Common Stock for $72,000. 
A bank line of credit exists providing for borrow-
ings  of  up  to  $1,250,000.  Outstanding  debt  under
this line of credit is collateralized by accounts receiv-
able  and  inventory  and  bears  interest  at  2.25  per-
centage  points  over  the  30  day  LIBOR  rate.  The
Company did not utilize this line of credit during the
year and there was no debt outstanding under this line
as  of  December  31,  2003.  The  Company  made  a
$150,000  draw  on  this  line  of  credit  on  June  20,
2002, primarily to cover a royalty payment to Aicello.
The Company repaid this draw within a short period
of time, utilizing cash from operations.

The  Company  believes  that  current  financial
resources,  its  line  of  credit,  cash  generated  from
operations and the Company’s capacity for debt and/or
equity  financing  will  be  sufficient  to  fund  current
and anticipated business operations. The Company
also believes that its low debt levels and available line
of credit make it unlikely that a decrease in demand
for the Company’s products would impair the Com-
pany’s ability to fund operations. 

Capital Expenditures

The Company spent $245,000 on capital expendi-
tures  during  2003.  This  spending  included  plant
equipment upgrades to improve efficiency and safety,
additions to the Company’s business software, vehi-
cles,  improvements  to  the  Company’s  trade  show
booths and construction costs on the leased training
facility in Singapore.

Commitments for capital expenditures include ongo-
ing manufacturing equipment upgrades, development
equipment to modernize the capabilities and processes
of IKONICS’ laboratory, and research and development
to improve measurement and quality control processes.
These commitments are expected to be funded with
cash generated from operating activities.

International Activity

The  Company  markets  its  products  to  over  80
countries in North America, Europe, Latin America,
Asia and other parts of the world. Foreign sales were
approximately  32%  of  total  sales  during  2003  and
2002. Foreign sales in 2003 reflected higher sales to
China and a decrease in sales to India. Fluctuations of

2003 ANNUAL REPORT

5

Financial Results

certain  foreign  currencies  have  not  significantly
impacted the Company’s operations because the Com-
pany’s foreign sales are not concentrated in any one
region of the world. The Company believes its vul-
nerability  to  uncertainties  due  to  foreign  currency
fluctuations and general economic conditions in for-
eign countries is not significant.

Substantially all of the Company’s foreign trans-
actions are negotiated, invoiced and paid in U.S. dol-
lars. A portion of the Company’s foreign sales are
invoiced and paid in Eurodollars. IKONICS has not
implemented a hedging strategy to reduce the risk of
foreign currency translation exposures, which man-
agement does not believe to be significant based on the
scope  and  geographic  diversity  of  the  Company’s
foreign operations as of December 31, 2003.

Future Outlook

IKONICS has invested on average over 6% of its
sales  dollars  for  the  past  several  years  in  research
and development. The Company plans to maintain its
efforts  in  this  area  and  expedite  internal  product
development as well as form technological alliances
with outside experts to ensure commercialization of
new product opportunities. 

In addition to its traditional emphasis on domestic
markets, the Company will continue efforts to grow
its business internationally by attempting to develop
new markets and expanding market share where it has
already established a presence.

Other future activities undertaken to expand the
Company’s business may include acquisitions, build-
ing  expansion  and  additions,  equipment  additions,
new product development and marketing opportunities.

Recent Accounting Pronouncements

In April 2003, the FASB issued SFAS No. 149,
“Amendment of Statement 133 on Derivative Instru-
ments and Hedging Activities” (FAS 149). FAS 149
amends and clarifies financial accounting and reporting
for derivative instruments including certain derivative
instruments  embedded  in  other  contracts  and  for
hedging activities under FAS 133. FAS 149 is effective
for contracts entered into or modified after June 30, 2003
and for hedging relationships designated after June 30,
2003. The adoption of this statement did not have a
material impact on the Company’s financial statements.

Imaging Technologies for Global Markets

In  May  2003,  the  FASB  issued  SFAS  No.  150,
“Accounting for Certain Financial Instruments with
Characteristics of both Liabilities and Equity” (FAS
150).  FAS  150  clarifies  the  accounting  for  certain
financial instruments and characteristics of both lia-
bilities and equity and requires that those instruments
be classified as liabilities in statements of financial
position. Previously, many of these financial instru-
ments were classified as equity. FAS 150 is effective
for all financial instruments entered into or modified
after May 31, 2003 and is otherwise effective at the
beginning of the first interim period after June 15,
2003. The adoption of this statement did not have a
material impact on the Company’s financial statements.

MARKET FOR COMMON EQUITY AND
RELATED STOCKHOLDER MATTERS 

The Company’s Common Stock is traded on the
Nasdaq SmallCap Market under the symbol IKNX.
The following table sets forth, for the fiscal quarters
indicated, the high and low bid prices for the Com-
pany’s Common Stock as reported on both markets for
the  periods  indicated.  The  quotations  reflect  inter-
dealer prices without retail mark-up, mark-down or
commission, and may not represent actual transactions. 

HIGH

LOW

Fiscal Year Ended December 31, 2003:

First Quarter . . . . . . . . . . . . . . . . . . . . . . $6.25
Second Quarter . . . . . . . . . . . . . . . . . . . . . 5.78
Third Quarter. . . . . . . . . . . . . . . . . . . . . . . 6.25
Fourth Quarter. . . . . . . . . . . . . . . . . . . . . . 8.34

Fiscal Year Ended December 31, 2002:

First Quarter . . . . . . . . . . . . . . . . . . . . . . $3.25
Second Quarter . . . . . . . . . . . . . . . . . . . . . 3.27
Third Quarter. . . . . . . . . . . . . . . . . . . . . . . 3.49
Fourth Quarter. . . . . . . . . . . . . . . . . . . . . . 5.10

$3.05
3.90
4.92
5.55

$2.95
3.00
2.85
3.25

As of February 27, 2004, the Company had approx-
imately  580  shareholders  of  record.  The  Company
has  never  declared  or  paid  any  dividends  on  its
Common Stock.

6

IKONICS CORPORATION

Imaging Technologies for Global Markets

Financial Results

MANAGEMENT’S REPORT

FINANCIAL STATEMENTS

The  financial  statements  of  IKONICS  Corpora-
tion  have  been  prepared  by  company  management
who are responsible for their content.  These state-
ments have been prepared in accordance with account-
ing principles generally accepted in the United States
of America and, where appropriate, reflect estimates
based on judgements of management. 

IKONICS maintains a system of internal controls.
Our system provides reasonable assurance that assets
are protected, transactions are appropriately reported,
and established procedures are followed.

The  financial  statements  have  been  audited  by

McGladrey & Pullen LLP, independent auditors.

The Audit Committee of the Board of Directors,
comprised  of  outside  directors,  meets  periodically
with  the  independent  auditors  and  management  to
discuss the company’s internal accounting controls and
financial reporting matters.  The independent auditors
have  unrestricted  access  to  the  Audit  Committee,
without management present, to discuss the results of
their audit, the adequacy of internal accounting con-
trols, and the quality of financial reports.

William C. Ulland
Chairman, President & CEO

Jon Gerlach
Chief Financial Officer

Independent Auditor’s Report

Stockholders and Board of Directors
IKONICS Corporation

We have audited the accompanying balance sheets
of IKONICS Corporation as of December 31, 2003
and 2002, and the related statements of operations,
stockholders’  equity  and  cash  flows  for  the  years
then ended. These financial statements are the respon-
sibility of the Company’s management. Our respon-
sibility  is  to  express  an  opinion  on  these  financial
statements based on our audits. 

We conducted our audits in accordance with audit-
ing standards generally accepted in the United States
of  America.  Those  standards  require  that  we  plan
and perform the audit to obtain reasonable assurance
about  whether  the  financial  statements  are  free  of
material misstatement. An audit includes examining,
on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also
includes  assessing  the  accounting  principles  used
and significant estimates made by management, as
well  as  evaluating  the  overall  financial  statement
presentation.  We  believe  that  our  audits  provide  a
reasonable basis for our opinion.

In our opinion, the financial statements referred to
above present fairly, in all material respects, the finan-
cial position of IKONICS Corporation as of Decem-
ber 31, 2003 and 2002, and the results of its operations
and its cash flows for the years then ended in con-
formity with accounting principles generally accepted
in the United States of America.

McGladrey & Pullen, LLP
Duluth, Minnesota
February 6, 2004

2003 ANNUAL REPORT

7

Balance Sheets

December 31, 2003 and 2002

Imaging Technologies for Global Markets

2003

2002

ASSETS

CURRENT ASSETS:

Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 1,507,794
Marketable securities  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
221,907
Trade receivables, less allowance for doubtful accounts of $100,000  . . . . . . .  1,859,480

$      384,107
246,094
1,933,769

in 2003 and 2002

Inventories (Note 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,807,233
73,260
Prepaid expenses and other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Income tax refund receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
0
128,000
Deferred taxes (Note 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5,597,674

1,771,905
89,937
122,469
82,000
__________
4,630,281

PROPERTY, PLANT, AND EQUIPMENT, at cost:

Land and building . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,406,377
Machinery and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2,337,166
Office equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,185,098
191,628 
Vehicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
5,120,269
Less accumulated depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,010,110
__________
1,110,159

1,355,588
2,231,478
1,144,564
167,102
__________
4,898,732
3,694,105
__________
1,204,627

INTANGIBLE ASSETS, less accumulated amortization of $85,154 in . . . . . . . . 

308,017

271,751

2003 and $60,966 in 2002 (Note 4)

DEFERRED TAXES (Note 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
OTHER ASSETS (Note 1). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

66,000
112,834
__________
$   7,194,684
__________
__________

118,000
187,500
__________
$   6,412,159
__________
__________

LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES:

Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $      264,744
227,318
Accrued compensation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
207,506
Other accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
126,766
Income taxes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
826,334
Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

$      317,229
204,624
23,643
0
__________
545,496

STOCKHOLDERS’ EQUITY:

Preferred stock, par value $.10 per share; authorized 250,000 shares;

issued none

Common stock, par value $.10 per share; authorized 4,750,000 shares;

issued and outstanding 1,248,127 shares-2003 and 2002  . . . . . . . . . . . . . . . 

124,813
Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,269,489
Retained earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,987,311
(13,263)
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
Total stockholders’ equity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,368,350
__________
$   7,194,684
__________
__________

124,813
1,269,489
4,483,895
(11,534) 
__________
5,866,663
__________
$   6,412,159
__________
__________

See notes to financial statements.

8

IKONICS CORPORATION

Imaging Technologies for Global Markets

Statements of Operations

Years ended December 31, 2003 and 2002

2003

2002

NET SALES. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 12,105,127

$ 11,797,279

COSTS AND EXPENSES:

Cost of goods sold . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6,601,263
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4,181,486
631,658
Research and development. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11,414,407
__________

6,808,130
3,835,097
706,343
__________
11,349,570
__________

INCOME FROM OPERATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

690,720

447,709

LOSS ON INVESTMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

(74,666) 

0

INTEREST INCOME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

16,362
__________

13,108
__________

INCOME BEFORE INCOME TAXES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

632,416

460,817

FEDERAL AND STATE INCOME TAXES (Note 3). . . . . . . . . . . . . . . . . . . . . . 

129,000
__________

101,000
__________

NET INCOME  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $      503,416
__________
__________

$      359,817
__________
__________

EARNINGS PER SHARE:

Basic. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $            0.40
__________
__________
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $            0.40
__________
__________

$            0.29 
__________
__________
$            0.29 
__________
__________

WEIGHTED AVERAGE COMMON SHARES 

ASSUMED OUTSTANDING:
Basic. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,248,127
__________
__________
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1,263,404
__________
__________

1,252,020
__________
__________
1,252,809
__________
__________

See notes to financial statements.

2003 ANNUAL REPORT

9

Statements of
Stockholders’ Equity

Years Ended December 31, 2003 and 2002

Imaging Technologies for Global Markets

Common Stock
Shares

Amount

Additional
Paid-in
Capital

Retained
Earnings

Accumulated
Other
Comprehensive
Income
(Loss)

Total
Equity

BALANCE AT
DECEMBER 31, 2001 . . . . .  1,271,627

$  127,163 $1,293,460 $4,170,246

$  (10,829) $5,580,040

Net income 
Unrealized loss on
available-for-sale
investments

Total comprehensive income

Purchase and retirement of
23,500 shares of common stock

359,817 

359,817

(705)

(705)
________
359,112

(23,500)
________

(2,350)
________

(23,971)
________

(46,168)
________

________

(72,489)
________

BALANCE AT
DECEMBER 31, 2002 . . . . . . 1,248,127

124,813

1,269,489

4,483,895

(11,534)

5,866,663

503,416

503,416

Total comprehensive income

________

________

________

________

________

(1,729)

(1,729)
________
501,687
________

BALANCE AT
DECEMBER 31, 2003 . . . . . . 1,248,127
________
________

$  124,813 $1,269,489 $4,987,311
________
________
________
________
________
________

$  (13,263) $6,368,350
________
________
________
________

See notes to financial statements.

10

IKONICS CORPORATION

Net income
Unrealized loss on
available-for-sale
investments

Imaging Technologies for Global Markets

Statements of Cash Flows

Years ended December 31, 2003 and 2002

2003

2002

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $      503,416
Adjustments to reconcile net income to net cash provided by

$      359,817

operating activities:

Depreciation  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Gain on sale of property and equipment . . . . . . . . . . . . . . . . . . . . . . . . . 
Loss on investment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Provision for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Deferred income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Changes in working capital components:

339,041
24,188
(5,500)
74,666
81,254
6,000

314,364
18,178
(13,116)
0
60,183
81,000

(Increase) decrease in:

Trade receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Inventories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Prepaid expenses and other assets . . . . . . . . . . . . . . . . . . . . . . . . . 
Income taxes refund receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . 

(6,965)
(35,328)
16,677
122,469

(520,970)
(166,235)
28,241
10,561

(Decrease) increase in:

Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Income taxes payable  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Net cash provided by operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

(52,485)
206,557
126,766
__________
1,400,756

19,673
57,421
0  
__________
249,117

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchase of property and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Proceeds on sale of property and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . 
Purchase of intangibles. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Purchases of marketable securities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Proceeds from sale of marketable securities . . . . . . . . . . . . . . . . . . . . . . . . . . 
Net cash used in investing activities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

(244,573)
5,500
(60,454)
(83,980)
106,438
__________
(277,069)

(250,366)
47,250
(123,439) 
(9,645)
0
__________
(336,200)

CASH FLOWS FROM FINANCING ACTIVITIES:

Repurchase of company stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

0
__________

(72,489)
__________

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS. . . . 

1,123,687

(159,572)

CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR. . . . . . . . . . 

384,107
__________

543,679
__________

CASH AND CASH EQUIVALENTS AT END OF YEAR. . . . . . . . . . . . . . . . . $   1,507,794
__________
__________

$      384,107
__________
__________

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION -

Cash paid (refunded) for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $   (126,514)
__________
__________
Cash paid for interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $                 0
__________
__________

$       (5,472)
__________
__________
$             503
__________
__________

See notes to financial statements.

2003 ANNUAL REPORT

11

Notes to
Financial Statements

Years Ended December 31, 2003 and 2002

Imaging Technologies for Global Markets

1. SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
Description of Business – IKONICS Corporation
(the Company) develops and manufactures high-qual-
ity photochemical imaging systems for sale primarily
to  a  wide  range  of  printers  and  decorators  of  sur-
faces. Customers’ applications include textiles, bill-
boards, electronics, glassware, fine china, and many
other  industrial  and  commercial  applications.  The
Company’s  principal  markets  are  throughout  the
United States. In addition, the Company sells to West-
ern Europe, Latin America, Asia, and other parts of
the  world.  The  Company  extends credit  to  its cus-
tomers,  all  on  an  unsecured  basis,  on  terms  that  it
establishes for individual customers.

Fifty-three percent and forty-four percent, respec-
tively,  of  the  Company’s  accounts  receivable  at
December 31, 2003 and 2002 are due from foreign
customers.  The  foreign  receivables  are  composed
primarily  of  open  credit  arrangements  with  terms
ranging  from  45  to  90  days.  No  receivable  from  a
single customer exceeded 10% of total receivables at
December 31, 2003 or December 31, 2002. No single
customer represented greater than 10% of total rev-
enue in 2003. One customer accounted for 17.6% of
total receivables at December 31, 2002.

A summary of the Company’s significant account-

ing policies follows:

Cash  Equivalents –  The  Company  considers  all
highly liquid debt instruments purchased with a matu-
rity of three months or less to be cash equivalents.
Cash  equivalents  consist  of  putable  variable  rate
municipal  bonds  backed  by  a  letter  of  credit  and
money market funds in which carrying value of both
instruments approximates market value because of the
short maturity of these instruments.

Marketable Securities – Marketable securities are
classified as available-for-sale securities and consist
primarily  of  municipal  revenue  bonds  that  will  be
held for indefinite periods of time, including securi-
ties that may be sold in response to changes in market
interest or prepayment rates, needs for liquidity, or
changes  in  the  availability  or  yield  of  alternative
investments. These securities are carried at fair market
value with changes in fair value recorded in compre-
hensive income. 

The majority of these municipal bonds have been
in  a  continuous  loss  position  for  over  12  months.

The fair value of municipal bonds that have been in
continuous loss for 12 months or more at December
31,  2003  is  $116,840  with  unrealized  losses  of
$13,022. The fair value of municipal bonds that have
been in continuous loss for less than 12 months at
December 31, 2003 is $56,920 with unrealized losses
of $1,337. The unrealized losses are generally due to
changes in interest rates, and as such, are considered
to be temporary, by the Company.

Trade Receivables – Trade receivables are carried
at original invoice amount less an estimate made for
doubtful  receivables  based  on  a  review  of  all  out-
standing  amounts  on  an  on-going  basis.  Manage-
ment determines the allowance for doubtful accounts
by regularly evaluating individual customer receiv-
ables and considering a customer’s financial condition,
credit history, and current economic conditions. Trade
receivables are written off when deemed uncollectible.
Recoveries  of  trade  receivables  previously  written
off are recorded when received. Accounts are con-
sidered past due if payment is not received according
to agreed-upon terms. 

Inventories – Inventories are stated at the lower of
cost  or  market  using  the  last-in,  first-out  (LIFO)
method. If the first-in, first-out cost method had been
used,  inventories  would  have  been  approximately
$264,000  and  $224,000  higher  than  reported  at
December 31, 2003 and 2002, respectively. The major
components of inventories are as follows:

2003

2002

Raw materials. . . . . . . . . $    928,949 $    735,006
257,813
Work-in-progress . . . . . . 
1,003,342
Finished goods . . . . . . . . 
(224,256)
Reduction to LIFO cost . . 
_________
Total inventories. . . . . . . $ 1,807,233 $ 1,771,905
_________
_________

231,269
911,419
(264,404)
_________
_________
_________

Depreciation – Depreciation of property and equip-
ment is computed using the straight-line method over
the following estimated useful lives:

YEARS

Building . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15-40
Machinery and equipment . . . . . . . . . . . . . . . . 5-10
Office equipment . . . . . . . . . . . . . . . . . . . . . . . 5-10
Vehicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

12

IKONICS CORPORATION

Imaging Technologies for Global Markets

Notes to
Financial Statements

Years Ended December 31, 2003 and 2002

Intangibles Assets –  Intangible assets consist pri-
marily of patents, licenses and covenants not to com-
pete arising from business combinations. Intangible
assets are amortized on a straight-line basis over their
estimated useful lives or terms of their agreement.

Other Assets – Other assets consist of a $112,834
equity  investment  in  Apprise  Technologies,  Inc.
This investment is accounted for on the cost method.
During the second quarter of 2003, the Company
wrote down the value of its investment in Apprise
Technologies, Inc. by $74,666. The latest issuance
price  for  shares  of  Apprise  was  below  the  value
carried  on  the  Company’s  books.  One  of  the
Company’s directors is the CEO of Apprise Tech-
nologies, Inc.

Impairment of Long-Lived Assets – Management
periodically reviews the carrying value of long-term
assets for potential impairment by comparing the car-
rying value of these assets to the estimated undis-
counted future cash flows expected to result from the
use of these assets. Should the sum of the related,
expected future net cash flows be less than the car-
rying value, an impairment loss would be measured.
An  impairment  loss  would  be  measured  by  the
amount  by  which  the  carrying  value  of  the  asset
exceeds the fair value of the asset with fair value
being determined using discounted cash flows. To
date, management has determined that no impair-
ment of these assets exists.

Revenue Recognition – The Company recognizes
revenue on products when title passes, which is usu-
ally  upon  shipment.  Freight  billed  to  customers  is
included in sales. Shipping costs are included in cost
of goods sold.

Deferred Taxes – Deferred taxes are provided on a
liability method whereby deferred tax assets are rec-
ognized for deductible temporary differences. Oper-
ating loss and tax credit carryforwards and deferred
tax liabilities are recognized for taxable temporary dif-
ferences. Temporary differences are the differences
between the reported amounts of assets and liabilities
and their tax bases. Deferred tax assets are reduced by
a valuation allowance when, in the opinion of man-
agement, it is more likely than not that some portion
or all of the deferred tax assets will not be realized.
Deferred  tax  assets  and  liabilities  are  adjusted  for
the effects of changes in tax laws and rates on the date
of enactment.

Comprehensive  Income –  The  Company’s  com-
prehensive  income  consists  of  net  income  and
unrealized gains and losses on marketable securities,
net of taxes.

Earnings Per Common Share (EPS) – Basic EPS
is calculated using net income divided by the weighted
average  of  common  shares  outstanding  during  the
year. Diluted EPS is similar to Basic except that the
weighted average of common shares outstanding is
increased to include the number of additional common
shares that would have been outstanding if the dilu-
tive potential common shares, such as options, had
been issued.

Shares used in the calculation of diluted EPS are

summarized below:

2003

2002

Weighted average
common shares
outstanding . . . . . . . . . . 1,248,127

Dilutive effect of

1,252,020

stock options . . . . . . . . . . . 15,277
_________

789
_________

Weighted average

common and common
equivalent shares
outstanding . . . . . . . . . . 1,263,404
_________
_________

1,252,809
_________
_________

Options to purchase 168,108 and 150,029 shares of
common stock were outstanding as of the years ended
December 31, 2003 and 2002, respectively. 

Employee  Stock  Plan –  The  Company  has  a
stock-based compensation plan, which is described
more fully in Note 7. The Company accounts for this
plan under the recognition and measurement prin-
ciples  of  APB  Opinion  No.  25,  Accounting  for
Stock Issued to Employees, and related interpreta-
tions. Accordingly, no stock-based employee com-
pensation cost has been recognized, as all options
granted under the plan had an exercise price equal
to the market value of the underlying common stock
on the date of grant. The following table illustrates
the  effect  on  net  income  and  earnings  per  share
had compensation cost been determined based on
the  grant  date  fair  values  of  awards  (the  method
described in FASB Statement No. 123, Accounting
for Stock-Based Compensation):

2003 ANNUAL REPORT

13

Notes to
Financial Statements

Years Ended December 31, 2003 and 2002

Imaging Technologies for Global Markets

financial  accounting  and  reporting  for  derivative
instruments including certain derivative instruments
embedded in other contracts and for hedging activi-
ties under FAS 133. FAS 149 is effective for contracts
entered into or modified after June 30, 2003 and for
hedging relationships designated after June 30, 2003.
The adoption of this statement did not have a mate-
rial impact on the Company’s financial statements.
In  May  2003,  the  FASB  issued  SFAS  No.  150,
“Accounting for Certain Financial Instruments with
Characteristics of both Liabilities and Equity” (FAS
150).  FAS  150  clarifies  the  accounting  for  certain
financial  instruments  and  characteristics  of  both
liabilities and equity and requires that those instru-
ments  be  classified  as  liabilities  in  statements  of
financial position. Previously, many of these financial
instruments  were  classified  as  equity.  FAS  150  is
effective for all financial instruments entered into or
modified after May 31, 2003 and is otherwise effec-
tive at the beginning of the first interim period after
June  15,  2003.  The  adoption  of  this  statement  did
not have a material impact on the Company’s finan-
cial statements.

2. STOCKHOLDERS’ EQUITY

During  the  year  ended  December  31,  2002,  the
Company repurchased 23,500 shares of its common
stock  for  $72,489,  which  shares  now  constitute
authorized  but  unissued  shares.  The  Company  did
not  repurchase  any  shares  during  the  year  ended
December 31, 2003.

YEARS ENDED DECEMBER 31,

2003

2002

Net income:

As reported. . . . . . . . . . . $503,416

$359,817

Deduct total stock-based

employee compensation
expense determined under
fair value based method 
for all awards . . . . . . . . . . . 79,377
_________

110,365
_________

Pro forma . . . . . . . . . . . . . . $424,039
_________

$249,452
_________

Basic earnings per share:

As reported. . . . . . . . . . . . . . $0.40
Pro forma . . . . . . . . . . . . . . . $0.34

Diluted earnings per share:

As reported. . . . . . . . . . . . . . $0.40

Pro forma . . . . . . . . . . . . . . . $0.34

$0.29
$0.20

$0.29

$0.20

Use of Estimates – The preparation of the financial
statements in conformity with accounting principles
generally accepted in the United States of America
requires management to make estimates and assump-
tions that affect the reported amounts of assets and lia-
bilities  and  disclosure  of  contingent  assets  and
liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the
reporting  period.  Actual  results  could  differ  from
those estimates.

Foreign  Operations –  The  Company  markets  in
Europe, Latin America, Asia, and other parts of the
world. Foreign sales approximated 32% total sales in
2003 and 2002.

Line of Credit – The Company has a $1,250,000
bank line of credit that provides for working capital
financing.  This  line  of  credit  is  subject  to  annual
renewal  on  each  May  1,  is  collateralized  by  trade
receivables and inventory, and bears interest at 2.25%
points over 30-day LIBOR. There was no outstand-
ing balance at December 31, 2003 and 2002.

Accounting Pronouncements – In April 2003, the
FASB issued SFAS No. 149, “Amendment of State-
ment  133  on  Derivative  Instruments  and  Hedging
Activities” (FAS 149). FAS 149 amends and clarifies

14

IKONICS CORPORATION

Imaging Technologies for Global Markets

Notes to
Financial Statements

Years Ended December 31, 2003 and 2002

3. INCOME TAXES

Income tax expense for the years ended December 31, 2003 and 2002 consists of the following:

2003

2002

Current:

Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

Federal. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $     100,000
23,000
State. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
123,000
6,000
__________
$     129,000
__________
__________

$       10,000
10,000
__________
20,000
81,000
__________
$     101,000
__________
__________
The expected provision for income taxes, computed by applying the U.S. federal income tax rate of 35% to income
before taxes, is reconciled to income tax expense as follows:

2003

2002

Expected provision for federal income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . $     221,200
13,700
State income taxes, net of federal benefit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
(127,800)
Extraterritorial income exclusion  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
10,200
Meals and entertainment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
(3,500)
Tax-exempt interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
(7,600)
R&D Credit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
28,000
Apprise valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
(5,200)
Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
$     129,000
__________
__________

$161,200
10,100
(78,800)
13,600
(3,900)
(9,000)
0
7,800
__________
$     101,000
__________
__________

Deferred tax assets consist of the following as of December 31, 2003 and 2002:

2003

2002

Property and equipment and other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $       35,000
16,000
Accrued vacation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
57,000
Other accrued expenses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
36,000
Inventories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
36,000
Allowance for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
7,000
Allowance for sales returns. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
31,000
Intangible assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
46,000
Capital loss carryforward . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
264,000
(46,000)
__________
218,000

Less valuation allowance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

$       61,000
27,000
0
12,000
36,000
7,000
57,000
20,000
__________
220,000
(20,000)
__________
200,000

Deferred tax liabilities:
Prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

0
__________
$     200,000
__________
__________
The components giving rise to the net deferred tax assets described above have been included in the accompanying
balance sheet as of December 31, 2003 and 2002 as follows:

24,000
__________
$     194,000
__________
__________

Current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $     128,000
66,000
Noncurrent assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
__________
$194,000
__________
__________

$       82,000
118,000
__________
$200,000
__________
__________
The noncurrent deferred tax assets are net of the valuation allowance. The Company increased its valuation
allowance by $26,000 during 2003 because of the additional capital loss carryforward which may not be utilized.

2003 ANNUAL REPORT

15

Notes to
Financial Statements

Years Ended December 31, 2003 and 2002

Imaging Technologies for Global Markets

4. INTANGIBLE ASSETS
Intangible assets consist primarily of patents, licenses and covenants not to compete arising from business com-
binations. Intangible assets are amortized on a straight-line basis over their estimated useful lives or terms of
their agreement. 
Intangible assets at December 31, 2003 and 2002 consist of the following:

December 31, 2003
Gross Carrying Accumulated
Amortization

Amount 

December 31, 2002
Gross Carrying Accumulated
Amortization

Amount

Amortized intangible assets:

Patents . . . . . . . . . . . . . . . . . . . . . . . . . . . $  193,171
Licenses . . . . . . . . . . . . . . . . . . . . . . . . . . 
100,000
Non-compete agreement . . . . . . . . . . . . .  100,000
________
$  393,171
________
________
Net intangible assets as December 31, 2003 and 2002 are $308,017 and $271,751, respectively.

$  (51,197)
(10,625)
(23,332)
________
$  (85,154)
________
________

$  132,717
100,000
100,000
________
$  332,717
________
________

$  (41,800)
(2,500)
(16,666)
________
$  (60,966)
________
________

2003

2002

Aggregate amortization expense:

For the year ended December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $    24,188

$     18,178

Estimated amortization expense:

For the year ended December 31, 2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $     28,400
28,400
For the year ended December 31, 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
28,400
For the year ended December 31, 2006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
28,400
For the year ended December 31, 2007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
28,400
For the year ended December 31, 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

In connection with the license agreements, the Company has agreed to pay royalties ranging from 3% to 5%
on the future sales of products subject to the agreements.

5. PENSION PLAN
The Company has established a salary deferral plan under Section 401(k) of the Internal Revenue Code. The
plan allows eligible employees to defer up to 15% of their compensation. Such deferrals accumulate on a tax-
deferred basis until the employee withdraws the funds. The Company contributes 5% of each eligible employee’s
compensation. Total pension expense for the years ended December 31, 2003 and 2002 was approximately
$138,000 and $145,000, respectively.

6. GEOGRAPHIC INFORMATION
The Company manages and operates its business on the basis of one reportable segment. See Note 1 for a brief
description of the Company’s business. As of December 31, 2003, the Company had operations established in
various countries throughout the world. The Company is exposed to the risk of changes in social, political, and
economic conditions inherent in foreign operations, and the Company’s results of operations are affected by
fluctuations in foreign currency exchange rates. No single foreign country accounted for more than 10% of the
Company’s net sales for 2003 and 2002. Net sales by geographic area are presented by attributing revenues from
external customers on the basis of where the products are sold.

2003

2002

Net sales by geographic area:

United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $  8,190,798
International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  3,914,329
__________
$12,105,127
__________
__________

$  8,045,967
3,751,312
__________
$11,797,279
__________
__________

16

IKONICS CORPORATION

Imaging Technologies for Global Markets

Notes to
Financial Statements

Years Ended December 31, 2003 and 2002

7. STOCK OPTIONS
During 1995, the Company adopted a stock incentive plan for the issuance of up to 38,500 shares of common
stock. In 1999, the Company increased the number of shares reserved for issuance under this plan to 203,500
shares. The plan provides for granting eligible participants stock options or other stock awards, as described
by the plan, at option prices ranging from 85% to 110% of fair market value at date of grant. Options granted
expire up to seven years after the date of grant. Such options generally become exercisable over a one- to three-
year period. 

2003

2002

Dividend yield. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.0%
Expected volatility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73.5%
Expected life of option. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . five years
Risk-free interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.0%
Fair value of each option on grant date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $2.61

0.0%
72.5%
five years
4.4%
$2.00

A summary of the status of the Company’s stock option plan as of December 31, 2003 and 2002 and changes
during the years ending on those dates is presented below:

2003
__________________
Weighted
Average
Exercise
Price

Shares

2002
__________________
Weighted
Average
Exercise
Price

Shares

Outstanding at beginning of year . . . . . . . . . . . . . . . . . . . . 150,029
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33,579
Exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0
Expired and forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (15,500)
Outstanding at end of year . . . . . . . . . . . . . . . . . . . . . . . . . 168,108

$5.93
4.30

5.74
5.50

142.920
26,079
0
(18,970)
150,029

$6.20
3.17

4.14
5.93

The following table summarizes information about stock options outstanding at December 31, 2003:

Range of
Exercise
Price

$3.00 - 3.99
4.00 - 4.99
5.00 - 5.99
6.00 - 6.99
7.00 - 7.99
8.00 - 8.99
9.00 - 9.99

Options Outstanding
__________________________________

Options Exercisable
________________________________

Number
Outstanding at
December 31,
2003

Weighted-
Average
Remaining
Contractual
Life

Weighted-
Average
Exercise
Price

Number
Exercisable at
December 31,
2003

Weighted-
Average
Exercise
Price

23,579
65,204
16,975
26,000 
5,000
18,150
13,200
_______
168,108
_______
_______

3.42
3.00
3.00
1.32
1.32
2.32
1.80
3.36

$3.18
4.40
5.08
6.56
7.22
8.18
9.15
5.50

15,355
42,279
9,141
26,000
5,000
18,150
13,200
_______
129,125 
_______
_______

$3.21
4.48
5.10
6.56
7.22
8.18
9.15
5.90

2003 ANNUAL REPORT

17

Notes to
Financial Statements

Years Ended December 31, 2003 and 2002

Imaging Technologies for Global Markets

8. Concentration of Credit Risk

10. Contingencies

The  Company  has  entered  into  licensing  agree-
ments which require it to make royalty payments on
sales  of  certain  products.  Royalty  payments  range
from 3% to 5% of net sales on these products. The
Company incurred $107,444 of expense under these
agreements during 2003, as compared to $119,792
during 2002.

The  Company  has  identified  the  probable  under
payment  of  sales  tax.  Accordingly,  the  Company
accrued $160,000 for the future payment of the unpaid
sales taxes.

The Company maintains its cash balances prima-
rily in one financial institution. As of December 31,
2003, the balance exceeded the Federal Deposit Insur-
ance Corporation coverage. The Company reduces its
exposure to credit risk by maintaining such balances
with financial institutions that have high credit ratings.
Accounts receivable are financial instruments that
also expose the Company to concentration of credit
risk. The large number of customers comprising the
Company’s customer base and their dispersion across
different geographic areas limits such exposure. In
addition, the Company routinely assesses the financial
strength of its customers and maintains an allowance
for doubtful accounts that management believes will
adequately provide for credit losses.

Concentration of credit risk with respect to trade
receivables  is  not  significant.  No  one  customer
accounts for more than 10% of total receivables as of
December 31, 2003.

9. Lease Commitments

As of December 31, 2003, the Company was obli-
gated  under  non-cancelable  operating  lease  agree-
ments for certain equipment and a building. Future
minimum lease payments for non-cancelable operat-
ing leases with initial or remaining terms in excess of
one year are as follows: 

2004 . . . . . . . . . . . . . . . . . . $  41,028
2005 . . . . . . . . . . . . . . . . . . $  20,012
2006 . . . . . . . . . . . . . . . . . . $    3,261

The Company also leases buildings on a month-to-
month basis. Total rental expense for all equipment
and building operating leases was $54,729 in 2003 and
$77,040 in 2002.

18

IKONICS CORPORATION

Imaging Technologies for Global Markets

5-Year History

Net Sales
Pretax Income (Loss)
Net Income (Loss)
Net Cash Provided
by Operations

Return on Sales
Return on Assets
Return on Avg.
Stockholders' Equity
Debt to Equity

Diluted EPS
Stock price: High
Low
Close

Weighted Average
Shares Outstanding
Weighted Average
Shares & Equivalent
Shares Outstanding*

1999

2000

2001

2002

2003

$ 10,382,227
$   1,234,794
$      803,793

$ 10,367,270
$      364,007
$      255,007

$ 10,752,133
$  (297,901)
$ (205,901)

$ 11,797,279
$      460,817
$      359,817

$ 12,105,127
$      632,416
$      503,416

$   1,096,463

$      182,527

$      356,035

$      249,117

$   1,400,756

7.7%
13.1%

15.3%
8.8%

2.5%
4.0%

4.5%
9.6%

-1.9%
-3.4%

-3.6%
8.4%

3.0%
5.6%

6.3%
9.3%

4.2%
7.0%

8.2%
13.0%

$            0.62
$            8.41
$            6.14
$            7.25

$            0.20
$            7.50
$            4.00
$            4.88

( 0.16)
$  
$            5.25
$            2.62
$            3.00

$            0.29
$            5.10
$            2.85
$            3.30

$            0.40
$            8.34
$            3.05
$            6.30

1,297,519

1,295,239

1,271,627

1,252,020

1,248,127

1,305,995

1,301,311

1,271,627

1,252,809

1,263,404

Total Assets
Total Liabilities
Total Stockholders' Equity
Capital Spending

$   6,159,003
$      497,528
$   5,661,475
$      491,269

$   6,338,581
$      552,644
$   5,785,937
$      230,379

$   6,048,442
$      468,402
$   5,580,040
$      259,230

$   6,412,159
$      545,496
$   5,866,663
$      250,366

$   7,194,684
$      826,334
$   6,368,350
$      244,573

*Share & per share amounts have been adjusted for the 10% stock dividend on 12/31/99.

Common Stock
IKONICS  Corporation  common
stock  is  traded  on  the  Nasdaq
SmallCap Market (ticker symbol:
IKNX). For investment and stock
information, contact:

Jon Gerlach, CFO
IKONICS Corporation
4832 Grand Avenue
Duluth, MN 55807
PH: 218-628-2217
e-mail: jgerlach@ikonics.com

Transfer Agent
Wells Fargo Shareowner Services
161 North Concord Exchange
South St. Paul, MN 55075-1139

Shareholders  with  questions  on
stock  holdings,  transfer  require-
ments and address changes contact
Wells Fargo Bank at 651-450-4058
or 651-306-4341.

Auditor
McGladrey & Pullen LLP
700 Missabe Building
227 W. First Street
Duluth, MN 55802
218-727-5025

Counsel
Hanft Fride
1000 U.S. Bank Place
130 W. Superior Street
Duluth, MN  55802
218-722-4766

2003 ANNUAL REPORT

19

Board of Directors/Officers

Imaging Technologies for Global Markets

Board of Directors

Officers

Robert D. Banks
Vice-President, International

Toshifumi Komatsu
Vice-President, Technology

Jon Gerlach
Chief Financial Officer

Claude Piguet
Executive Vice-President

William C. Ulland
Chairman of the Board, President & CEO

ADDITIONAL FINANCIAL INFORMATION
Stockholders of record automatically receive quarterly
earnings information, and street name holders may do
so upon written request. For a copy of the Form 10-KSB,
as filed with the Securities and Exchange Commission,
and other financial information available at no change
to stockholders, please contact:

Jon Gerlach, Chief Financial Officer
IKONICS Corporation
4832 Grand Avenue, Duluth, MN 55807
Ph: 218-628-2217 • Email: jgerlach@ikonics.com

ANNUAL MEETING
The Company’s annual meeting will be held April 29,
2004 at 1:00 p.m. at the Kitchi Gammi Club, 831 East
Superior Street, Duluth, MN.

Charles H. Andresen
Attorney/Shareholder
Andresen, Haag, Paciotti,
& Butterworth P.A.
Duluth, MN
Director since 1979

Rondi Erickson
CEO/Director
Apprise Technologies, Inc.
Duluth, MN
Director since 2000

David O. Harris
President
David O. Harris, Inc.
Minneapolis, MN
Director since 1965

H. Leigh Severance
President
Severance Capital Management
Denver, CO
Director since 2000

Gerald W. Simonson
Venture Capital Investor President
Omnetics Connector Corp.
Minneapolis, MN
Director since 1978

William C. Ulland
Chairman of the Board,
President & CEO
IKONICS Corporation
Duluth, MN
Director since 1972

20

IKONICS CORPORATION

IKONICS Global

IKONICS
Global

Global commerce is not a novelty. Conducting

business  in  over  80  countries,  international

business  accounts  for  a  full  third  of  overall

revenue at IKONICS. 

The aim at IKONICS is to be “first and most”

in many niche markets that may or may not be

presently  inhabited  by  industry  peers  and

competitors. As such, efforts throughout 2003

are anticipated to result in significant improve-

ment in the distribution, support and sale of

Chromaline and PhotoBrasive products across

the globe in 2004 and beyond. 

In 2003, the push to diversify the scope of our

international  business  was  fortified  with  the

establishment of a training center in Singapore.

This  commitment to  market  development  is

indicative  of  the  aggressive  targeting  that

defines the appetite for growth at IKONICS.

4832 Grand Avenue • Duluth, MN 55807 • PH: 218-628-2217 • Fax: 218-628-3245

www.ikonics.com • info@ikonics.com